Local firm pushes New Zealand as viable clinical trials destination for international firms
This article was originally published in Clinica
Executive Summary
New Zealand company BELTAS is claiming a unique position as the only local firm on the country's medical contract research market. Covering devices, cardiology, oncology, diabetes, immunology, neurology and respiratory medicine, it claims to have achieved global status within just three years, specialising in the needs of companies for research sites in Australia and Europe besides New Zealand.